Contrast Sensitivity in Patients with Beta-Thalassemia Major and Sickle Cell Disease Under Regular Transfusions and Treatment with Desferrioxamine

PURPOSE: Evaluation of contrast sensitivity in patients with beta-thalassemia major and sickle cell disease which undergo regular transfusions and chelation therapy with desferrioxamine (DFX). MATERIALS AND METHODS: We studied contrast sensitivity in 48 eyes (24 patients) with beta-thalassemia major...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorezis, Spyridon, Asproudis, Ioannis, Chalasios, Nikolaos, Karali, Aikaterini, Tsanou, Elena, Peschos, Dimitrios, Christodoulou, Aikaterini, Aspiotis, Miltiadis
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944988/
https://www.ncbi.nlm.nih.gov/pubmed/20871749
http://dx.doi.org/10.2174/1874364101004010039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944988/
https://www.ncbi.nlm.nih.gov/pubmed/20871749
http://dx.doi.org/10.2174/1874364101004010039

Ejemplares similares